XML 120 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at Dec. 31, 2021 $ 225,266 $ 0 $ 522,486 $ (155) $ (297,065)
Balance, Shares at Dec. 31, 2021   2,763,734      
Stock-based compensation 41,315   41,315    
Issuance of common stock, upon vesting of restricted stock, Shares   83,139      
Purchase of common stock under the 2020 Employee Stock Purchase Plan 536   536    
Purchase of common stock under the 2020 employee stock purchase plan, Shares   6,828      
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs 126,425 $ 0 126,425    
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs, Shares   1,193,830      
Unrealized gain (loss) on available-for-sale securities (313)     (313)  
Net loss (168,710)       (168,710)
Balance at Dec. 31, 2022 224,519 $ 0 690,762 (468) (465,775)
Balance, Shares at Dec. 31, 2022   4,047,531      
Stock-based compensation 10,029   10,029    
Issuance of common stock, upon vesting of restricted stock, Shares   14,554      
Unrealized gain (loss) on available-for-sale securities 167     167  
Net loss (41,183)       (41,183)
Balance at Mar. 31, 2023 193,532 $ 0 700,791 (301) (506,958)
Balance, Shares at Mar. 31, 2023   4,062,085      
Balance at Dec. 31, 2022 224,519 $ 0 690,762 (468) (465,775)
Balance, Shares at Dec. 31, 2022   4,047,531      
Unrealized gain (loss) on available-for-sale securities 268        
Net loss (130,722)        
Balance at Sep. 30, 2023 195,334 $ 0 792,031 (200) (596,497)
Balance, Shares at Sep. 30, 2023   4,955,066      
Balance at Dec. 31, 2022 224,519 $ 0 690,762 (468) (465,775)
Balance, Shares at Dec. 31, 2022   4,047,531      
Stock-based compensation 40,779   40,779    
Issuance of common stock, upon vesting of restricted stock, Shares   40,065      
Purchase of common stock under the 2020 Employee Stock Purchase Plan 326   326    
Purchase of common stock under the 2020 employee stock purchase plan, Shares   5,836      
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs 70,169 $ 0 70,169    
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs, Shares   869,565      
Unrealized gain (loss) on available-for-sale securities 406     406  
Net loss (190,418)       (190,418)
Balance at Dec. 31, 2023 145,781 $ 0 802,036 (62) (656,193)
Balance, Shares at Dec. 31, 2023   4,962,997      
Balance at Mar. 31, 2023 193,532 $ 0 700,791 (301) (506,958)
Balance, Shares at Mar. 31, 2023   4,062,085      
Stock-based compensation 10,288   10,288    
Issuance of common stock, upon vesting of restricted stock, Shares   7,786      
Purchase of common stock under the 2020 Employee Stock Purchase Plan 315   315    
Purchase of common stock under the 2020 employee stock purchase plan, Shares   4,736      
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs 70,169 $ 0 70,169    
Issuance of common stock in public offering, net of underwriting discounts, commissions and offering costs, Shares   869,565      
Unrealized gain (loss) on available-for-sale securities 76     76  
Net loss (45,267)       (45,267)
Balance at Jun. 30, 2023 229,113 $ 0 781,563 (225) (552,225)
Balance, Shares at Jun. 30, 2023   4,944,172      
Stock-based compensation 10,468   10,468    
Issuance of common stock, upon vesting of restricted stock, Shares   10,894      
Unrealized gain (loss) on available-for-sale securities 25     25  
Net loss (44,272)       (44,272)
Balance at Sep. 30, 2023 195,334 $ 0 792,031 (200) (596,497)
Balance, Shares at Sep. 30, 2023   4,955,066      
Balance at Dec. 31, 2023 145,781 $ 0 802,036 (62) (656,193)
Balance, Shares at Dec. 31, 2023   4,962,997      
Stock-based compensation 5,034   5,034    
Issuance of common stock, upon vesting of restricted stock, Shares   31,859      
Unrealized gain (loss) on available-for-sale securities (76)     (76)  
Net loss (30,299)       (30,299)
Balance at Mar. 31, 2024 120,440 $ 0 807,070 (138) (686,492)
Balance, Shares at Mar. 31, 2024   4,994,856      
Balance at Dec. 31, 2023 145,781 $ 0 802,036 (62) (656,193)
Balance, Shares at Dec. 31, 2023   4,962,997      
Unrealized gain (loss) on available-for-sale securities (72)        
Net loss (40,501)        
Balance at Sep. 30, 2024 121,118 $ 0 817,946 (134) (696,694)
Balance, Shares at Sep. 30, 2024   5,019,048      
Balance at Mar. 31, 2024 120,440 $ 0 807,070 (138) (686,492)
Balance, Shares at Mar. 31, 2024   4,994,856      
Stock-based compensation 5,908   5,908    
Issuance of common stock, upon vesting of restricted stock, Shares   17,145      
Purchase of common stock under the 2020 Employee Stock Purchase Plan 21   21    
Purchase of common stock under the 2020 employee stock purchase plan, Shares   1,582      
Unrealized gain (loss) on available-for-sale securities (1)     (1)  
Net loss (6,076)       (6,076)
Balance at Jun. 30, 2024 120,292 $ 0 812,999 (139) (692,568)
Balance, Shares at Jun. 30, 2024   5,013,583      
Stock-based compensation 4,947   4,947    
Issuance of common stock, upon vesting of restricted stock, Shares   5,465      
Unrealized gain (loss) on available-for-sale securities 5     5  
Net loss (4,126)       (4,126)
Balance at Sep. 30, 2024 $ 121,118 $ 0 $ 817,946 $ (134) $ (696,694)
Balance, Shares at Sep. 30, 2024   5,019,048